Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Free Cash Flow: 2019-2025

Historic Free Cash Flow for IDEAYA Biosciences (IDYA) over the last 7 years, with Sep 2025 value amounting to $142.2 million.

  • IDEAYA Biosciences' Free Cash Flow rose 386.11% to $142.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$105.4 million, marking a year-over-year increase of 31.24%. This contributed to the annual value of -$251.4 million for FY2024, which is 113.82% down from last year.
  • Per IDEAYA Biosciences' latest filing, its Free Cash Flow stood at $142.2 million for Q3 2025, which was up 325.18% from -$63.1 million recorded in Q2 2025.
  • IDEAYA Biosciences' 5-year Free Cash Flow high stood at $142.2 million for Q3 2025, and its period low was -$122.8 million during Q4 2024.
  • Its 3-year average for Free Cash Flow is -$32.0 million, with a median of -$33.9 million in 2024.
  • As far as peak fluctuations go, IDEAYA Biosciences' Free Cash Flow tumbled by 399.30% in 2024, and later soared by 386.11% in 2025.
  • IDEAYA Biosciences' Free Cash Flow (Quarterly) stood at -$17.3 million in 2021, then plummeted by 35.38% to -$23.4 million in 2022, then decreased by 5.20% to -$24.6 million in 2023, then slumped by 399.30% to -$122.8 million in 2024, then surged by 386.11% to $142.2 million in 2025.
  • Its Free Cash Flow was $142.2 million in Q3 2025, compared to -$63.1 million in Q2 2025 and -$61.7 million in Q1 2025.